144 related articles for article (PubMed ID: 32605372)
1. A New Class of Dengue and West Nile Virus Protease Inhibitors with Submicromolar Activity in Reporter Gene DENV-2 Protease and Viral Replication Assays.
Kühl N; Graf D; Bock J; Behnam MAM; Leuthold MM; Klein CD
J Med Chem; 2020 Aug; 63(15):8179-8197. PubMed ID: 32605372
[TBL] [Abstract][Full Text] [Related]
2. Effects of NS2B-NS3 protease and furin inhibition on West Nile and Dengue virus replication.
Kouretova J; Hammamy MZ; Epp A; Hardes K; Kallis S; Zhang L; Hilgenfeld R; Bartenschlager R; Steinmetzer T
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):712-721. PubMed ID: 28385094
[TBL] [Abstract][Full Text] [Related]
3. Small molecule pan-dengue and West Nile virus NS3 protease inhibitors.
Cregar-Hernandez L; Jiao GS; Johnson AT; Lehrer AT; Wong TA; Margosiak SA
Antivir Chem Chemother; 2011 May; 21(5):209-17. PubMed ID: 21566267
[TBL] [Abstract][Full Text] [Related]
4. Beyond Basicity: Discovery of Nonbasic DENV-2 Protease Inhibitors with Potent Activity in Cell Culture.
Kühl N; Leuthold MM; Behnam MAM; Klein CD
J Med Chem; 2021 Apr; 64(8):4567-4587. PubMed ID: 33851839
[TBL] [Abstract][Full Text] [Related]
5. High-throughput screening for the identification of small-molecule inhibitors of the flaviviral protease.
Balasubramanian A; Manzano M; Teramoto T; Pilankatta R; Padmanabhan R
Antiviral Res; 2016 Oct; 134():6-16. PubMed ID: 27539384
[TBL] [Abstract][Full Text] [Related]
6. Identification and biochemical characterization of small-molecule inhibitors of west nile virus serine protease by a high-throughput screen.
Mueller NH; Pattabiraman N; Ansarah-Sobrinho C; Viswanathan P; Pierson TC; Padmanabhan R
Antimicrob Agents Chemother; 2008 Sep; 52(9):3385-93. PubMed ID: 18606844
[TBL] [Abstract][Full Text] [Related]
7. Tripeptide inhibitors of dengue and West Nile virus NS2B-NS3 protease.
Schüller A; Yin Z; Brian Chia CS; Doan DN; Kim HK; Shang L; Loh TP; Hill J; Vasudevan SG
Antiviral Res; 2011 Oct; 92(1):96-101. PubMed ID: 21763725
[TBL] [Abstract][Full Text] [Related]
8. Dual inhibitors of the dengue and West Nile virus NS2B-NS3 proteases: Synthesis, biological evaluation and docking studies of novel peptide-hybrids.
Bastos Lima A; Behnam MA; El Sherif Y; Nitsche C; Vechi SM; Klein CD
Bioorg Med Chem; 2015 Sep; 23(17):5748-55. PubMed ID: 26233795
[TBL] [Abstract][Full Text] [Related]
9. Discovery of Nanomolar Dengue and West Nile Virus Protease Inhibitors Containing a 4-Benzyloxyphenylglycine Residue.
Behnam MA; Graf D; Bartenschlager R; Zlotos DP; Klein CD
J Med Chem; 2015 Dec; 58(23):9354-70. PubMed ID: 26562070
[TBL] [Abstract][Full Text] [Related]
10. Amodiaquine, an antimalarial drug, inhibits dengue virus type 2 replication and infectivity.
Boonyasuppayakorn S; Reichert ED; Manzano M; Nagarajan K; Padmanabhan R
Antiviral Res; 2014 Jun; 106():125-34. PubMed ID: 24680954
[TBL] [Abstract][Full Text] [Related]
11. Phenylalanine and Phenylglycine Analogues as Arginine Mimetics in Dengue Protease Inhibitors.
Weigel LF; Nitsche C; Graf D; Bartenschlager R; Klein CD
J Med Chem; 2015 Oct; 58(19):7719-33. PubMed ID: 26367391
[TBL] [Abstract][Full Text] [Related]
12. Arylcyanoacrylamides as inhibitors of the Dengue and West Nile virus proteases.
Nitsche C; Steuer C; Klein CD
Bioorg Med Chem; 2011 Dec; 19(24):7318-37. PubMed ID: 22094280
[TBL] [Abstract][Full Text] [Related]
13. In vitro antiviral activity of spirotetronate compounds against dengue virus serotype 2.
Euanorasetr J; Intra B; Thunmrongsiri N; Limthongkul J; Ubol S; Anuegoonpipat A; Kurosu T; Ikuta K; Nihira T; Panbangred W
J Gen Appl Microbiol; 2019 Sep; 65(4):197-203. PubMed ID: 30814437
[TBL] [Abstract][Full Text] [Related]
14. Discovery of antiviral molecules for dengue: In silico search and biological evaluation.
Cabarcas-Montalvo M; Maldonado-Rojas W; Montes-Grajales D; Bertel-Sevilla A; Wagner-Döbler I; Sztajer H; Reck M; Flechas-Alarcon M; Ocazionez R; Olivero-Verbel J
Eur J Med Chem; 2016 Mar; 110():87-97. PubMed ID: 26807547
[TBL] [Abstract][Full Text] [Related]
15. Policresulen, a novel NS2B/NS3 protease inhibitor, effectively inhibits the replication of DENV2 virus in BHK-21 cells.
Wu DW; Mao F; Ye Y; Li J; Xu CL; Luo XM; Chen J; Shen X
Acta Pharmacol Sin; 2015 Sep; 36(9):1126-36. PubMed ID: 26279156
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of nonsubstrate based inhibitors of the essential dengue and West Nile virus proteases.
Ganesh VK; Muller N; Judge K; Luan CH; Padmanabhan R; Murthy KH
Bioorg Med Chem; 2005 Jan; 13(1):257-64. PubMed ID: 15582469
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of dengue virus replication by a class of small-molecule compounds that antagonize dopamine receptor d4 and downstream mitogen-activated protein kinase signaling.
Smith JL; Stein DA; Shum D; Fischer MA; Radu C; Bhinder B; Djaballah H; Nelson JA; Früh K; Hirsch AJ
J Virol; 2014 May; 88(10):5533-42. PubMed ID: 24599995
[TBL] [Abstract][Full Text] [Related]
18. A quinoline compound inhibits the replication of dengue virus serotypes 1-4 in Vero cells.
Beesetti H; Tyagi P; Medapi B; Krishna VS; Sriram D; Khanna N; Swaminathan S
Antivir Ther; 2018; 23(5):385-394. PubMed ID: 29583121
[TBL] [Abstract][Full Text] [Related]
19. Peptide derivatives as inhibitors of NS2B-NS3 protease from Dengue, West Nile, and Zika flaviviruses.
da Silva-Júnior EF; de Araújo-Júnior JX
Bioorg Med Chem; 2019 Sep; 27(18):3963-3978. PubMed ID: 31351847
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of dengue NS2B-NS3 protease and viral replication in Vero cells by recombinant retrocyclin-1.
Rothan HA; Han HC; Ramasamy TS; Othman S; Rahman NA; Yusof R
BMC Infect Dis; 2012 Nov; 12():314. PubMed ID: 23171075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
